Epstein Barr virus-associated lymphoproliferative-disorders primarily involving the skin

Journal of Cutaneous Pathology

Volumn 26, Issue 5, 1999, Pages 242-247

  Chai, Chiling ^a,c   White, Wain L ^b   Shea, Christopher R ^a   Prieto, Victor G ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIGEN; CD30 ANTIGEN; CD45 ANTIGEN; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; LEUKOSIALIN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; VIRUS PROTEIN;

ADULT; ARTICLE; B LYMPHOCYTE; CASE REPORT; CELL NUCLEUS; CLINICAL FEATURE; CYTOPLASM; DATA BASE; DERMATOMYOSITIS; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LYMPHOCYTE PROLIFERATION; LYMPHOPROLIFERATIVE DISEASE; MALE; SKIN BIOPSY; SKIN NECROSIS;

ADULT; ANTIGENS, CD; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSION; LYMPHOCYTES; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; SKIN DISEASES; VIRAL MATRIX PROTEINS; VIRUS ACTIVATION;

EID: 0033030180     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0560.1999.tb01837.x     Document Type: Article

References (31)

1. 1. Kamel OW. Iatrogenic lymphoproliferative disorders in non-transplantation settings. Semin Diagn Pathol 1997; 14: 27.
2. 2. Swerdlow SH. Classification of the posttransplant lymphoproliferative disorders: from the past to the present. Semin Diag Pathol 1997; 14: 2.
3. 3. Frizzera G, Hanto DW, Gajl-Peczalska KJ, et al. Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients. Cancer Res 1981; 41: 4262.
4. 4. Hanto DW, Gajl-Peczalska KJ, Frizzera G, et al. Epstein-Barr virus induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Clinical, pathologic, and virologic findings and implications for therapy. Ann Surg 1983; 198: 356.
5. 5. Garvin AJ, Self S, Sahovic EA, Stuart RK, Marchalonis JJ. The occurrence of a peripheral T-cell lymphoma in a chronically immunosuppressed renal transplant patient. Am J Surg Path 1988; 12: 64.
6. 6. Nalesnik MA, Jaffe R, Starzl TE, et al. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 1988; 133: 173.
7. 7. Kemnitz J, Cremer J, Gebel M, Uysal A, Haverich A, Georgii A. T-cell lymphoma after heart transplantation. Am J Clin Pathol 1990; 94: 95.
8. 8. Ferry JA, Jacobson JO, Conti D, Delmonico F, Harris NL. Lymphoproliferative disorders and hematologic malignancies following organ transplantation. Mod Pathol 1989; 2: 583.
9. 9. Randhawa PS, Yousem SA, Paradis IL, Dauber JA, Griffith BP, Locker J. The clinical spectrum, pathology, and clonal analysis of Epstein-Barr virus-associated lymphoproliferative disorders in heart-lung transplant recipients. Am J Clin Pathol 1989; 92: 177.
10. 10. Wilkinson AH, Smith JL, Hunsicker LG, et al. Increased frequency of posttransplant lymphomas in patients treated with cyclosporine, azathioprine, and prednisone. Transplantation 1989; 47: 293.
11. 11. Swinnen LJ, Costanzo-Nordin MR, Fisher SG, et al. Increased incidence of lymphoproliferative disorders after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients. N Engl J Med 1990; 323: 1723.
12. 12. Knowles DM, Cesarman E, Chadburn A, et al. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood 1995; 85: 552.
13. 13. Cleary ML, Warnke R, Sklar J. Monoclonality of lymphoproliferative lesions in cardiac-transplant recipients: Clonal analysis based on immunoglobulin-gene rearrangements. N Engl J Med 1984; 310: 477.
14. 14. Shearer WT, Ritz J, Finegold MJ, et al. Epstein-Barr virus-associated B-cell proliferations of diverse clonal origins after bone marrow transplantation in a 12-year-old patient with severe combined immunodeficiency. N Engl J Med 1985; 312: 1151.
15. 15. Jones JF, Shurin S, Abramowsky C, et al. T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections. N Engl J Med 1988; 318: 733.
16. 16. Leblond V, Davi F, Charlotte F, et al. Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus. A distinct entity. J Clin Oncol 1998; 16: 2052.
17. 17. Ballerini P, Gaidano G, Gong JZ, et al. Multiple genetic lesions in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Blood 1993; 81: 166.
18. 18. Gaidano G, Pastore C, Lanza C, Mazza U, Saglio G. Molecular pathology of AIDS-related lymphomas. Biologic aspects and clinicopathologic heterogeneity. Ann Hematol 1994; 69: 281.
19. 19. Ellman MH, Hurwitz H, Chinnama T, Kozloff M. Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate. J Rheumatol 1991; 18: 1741.
20. 20. Shiroky JB, Frost A, Skelton JD, Haegert DG, Newkirk MM, Neville C. Complications of immunosuppression associated with weekly low close methotrexate. J Rheumatol 1991; 18: 1172.
21. 21. Kamel OW, van der Rijn M, LeBrun DP, Weiss LM, Warnke RA, Dorfman RF. Lymphoid neoplasms in patients with rheumatoid arthritis and dermatomyositis: Frequency of Epstein-Barr virus and other features associated with immunosuppression. Hum Pathol 1994; 25: 638.
22. 22. Paul C, LeTourneau A, Cayucla JM, et al. Epstein-Barr virus-associated lymphoproliferative disease during methotrexate therapy for psoriasis. Arch Dermatol 1997; 1333: 867.
23. 23. Salloum E, Cooper DL, Howe G, et al. Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. J Clin Oncol 1996; 14: 1943.
24. 24. Reed JA, Manahan LJ, Park CS, Brigati DJ. Complete one-hour immunocytochemistry based on capillary action. Biotechniques 1992; 13: 434.
25. 25. Mozzanica N, Cattaneo A, Fracchiolla N, et al. Posttransplantation cutaneous B-cell lymphoma with monoclonal Epstein-Barr virus infection, responding to acyclovir and reduction in immunosuppression. J Heart Lung Transp 1997; 16: 964.
26. 26. Edwards RH, Raab-Traub N. Alterations of the p53 gene in Epstein-Barr virus-associated immunodeficiency-related lymphomas. J Virol 1994; 68: 1309.
27. 27. Jaffe ES. Post-thymic T-cell lymphomas. In: Jaffe ES, ed. Surgical pathology of the lymph node and related organs. 2nd ed. Philadelphia: W.B. Saunders, 1995.
28. 28. Haegert DG, Smith JL. Co-expression of T3 and surface immunoglobulin in neoplasms of "early" B cells: a report of 2 cases. Eur J Haematol 1987; 38: 213.
29. 29. Quintanilla-Martinez L, Preffer F, Rubin D, Ferry JA, Harris NL. CD204 T-cell lymphoma. Neoplastic transformation of a normal T-cell subset. Am J Clin Pathol 1994; 102: 483.
30. 30. Ritter JH, Adesokan PN, Fitzgibbon JF, Wick MR. Paraffin section immunohistochemistry as an adjunct to morphologic analysis in the diagnosis of cutaneous lymphoid infiltrates. J Cutan Pathol 1994; 21: 481.
31. 31. Magro CM, Crowson N, Harrist TJ. Atypical lymphoid infiltrates arising in cutaneous lesions of connective tissue diseases. Am J Dermatopathol 1997; 19: 446.